Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast

FEBS Journal

Volumn 273, Issue 22, 2006, Pages 5086-5100

  Barhoumi, Mourad ^a   Tanner, N K ^b   Banroques, Josette ^b,c   Linder, Patrick ^b   Guizani, Ikram ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c CNRS   (France)

Author keywords

ATPase; DEAD box; eIF4AIII; Leishmaniasis; Unwindase

Indexed keywords

ADENOSINE TRIPHOSPHATE DEPENDENT PROTEINASE; DEAD BOX PROTEIN; INITIATION FACTOR 4A; PROTEIN LEIF; PROTOZOAL PROTEIN; RNA HELICASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL GROWTH; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG PURIFICATION; ESCHERICHIA COLI; FUNGUS GROWTH; GENE DELETION; GENETIC ANALYSIS; GROWTH INHIBITION; IN VITRO STUDY; LEISHMANIA INFANTUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSLATION INITIATION;

ADENOSINE TRIPHOSPHATASES; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELL PROLIFERATION; EUKARYOTIC INITIATION FACTOR-4A; EUKARYOTIC INITIATION FACTOR-4G; FUNGAL PROTEINS; GENE DELETION; GREEN FLUORESCENT PROTEINS; LEISHMANIA INFANTUM; MOLECULAR SEQUENCE DATA; PEPTIDE INITIATION FACTORS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; RNA HELICASES; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID; YEASTS;

ESCHERICHIA COLI; EUKARYOTA; LEISHMANIA INFANTUM; SACCHAROMYCES CEREVISIAE;

EID: 33750599738     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05506.x     Document Type: Article

References (78)

1. de Almeida MC, Vilhena V, Barral A & Barral-Netto M (2003) Leishmanial infection: analysis of its first steps. A review. Mem Inst Oswaldo Cruz 98, 861-870.
2. Herwaldt BL (1999) Leishmaniasis. Lancet 354, 1191-1199.
3. Echeverria P, Dran G, Pereda G, Rico AI, Requena JM, Alonso C, Guarnera E & Angel SO (2001) Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination. Immunol Lett 76, 107-110.
4. Handman E, Button LL & McMaster RW (1990) Leishmania major: production of recombinant gp63, its antigenicity and immunogenicity in mice. Exp Parasitol 70, 427-435.
5. Handman E, Symons FM, Baldwin TM, Curtis JM & Scheerlinck JP (1995) Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response. Infect Immun 63, 4261-4267.
6. Masina SMMG, Demotz SO & Fasel NJ (2003) Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen. J Infect Dis 188, 1250-1257.
7. Mougneau E, Altare F, Wakil AE, Zheng S, Coppola T, Wang ZE, Waldmann R, Locksley RM & Glaichenhaus (1995) Expression cloning of a protective Leishmania antigen. Science 268, 563-566.
8. Probst P, Skeiky YA, Steeves M, Gervassi A, Grabstein KH & Reed SG (1997) A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells. Eur J Immunol 27, 2634-2642.
9. Ramiro MJ, Zarate JJ, Hanke T, Rodriguez D, Rodriguez JR, Esteban M, Lucientes J, Castillo JA & Larraga V (2003) Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 21, 2474-2484.
10. Skeiky YA, Guderian JA, Benson DR, Bacelar O, Carvalho EM, Kubin M, Badaro R, Trinchieri G & Reed SG (1995) A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12. J Exp Med 181, 1527-1537.
11. Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH et al. (1998) LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile. J Immunol 161, 6171-6179.
12. Tonui WK, Mejia JS, Hochberg L, Mbow ML, Ryan JR, Chan AS, Martin SK & Titus RG (2004) Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major. Infect Immun 72, 5654-5661.
13. Webb JR, Kaufmann D, Campos-Neto A & Reed SG (1996) Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. J Immunol 157, 5034-5041.
14. Borges MM, Campos-Neto A, Sleath P, Grabstein KH, Morrissey PJ, Skeiky YA & Reed SG (2001) Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein. Infect Immun 69, 5270-5277.
15. Skeiky YA, Coler RN, Brannon M, Stromberg E, Greeson K, Crane RT, Webb JR, Campos-Neto A & Reed SG (2002) Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. Vaccine 20, 3292-3303.
16. Badaro R, Lobo I, Nakatani M, Muinos A, Netto EM, Coler RN & Reed SG (2001) Successful use of a defined antigen/GM-CSF adjuvant vaccine to treat mucosal Leishmaniasis refractory to antimony: a case report. Braz J Infect Dis 5, 223-232.
17. Dhalia R, Reis CR, Freire ER, Rocha PO, Katz R, Muniz JR, Standart N & de Melo Neto OP (2005) Translation initiation in Leishmania major: characterisation of multiple eIF4F subunit homologues. Mol Biochem Parasitol 140, 23-41.
18. Linder P (2003) Yeast RNA helicases of the DEAD-box family involved in translation initiation. Biol Cell 95, 157-167.
19. Linder P, Lasko PF, Ashburner M, Leroy P, Nielsen PJ, Nishi K, Schnier J & Slonimski PP (1989) Birth of the D-E-A-D box. Nature 337, 121-122.
20. Gorbalenya AE & Koonin EV (1993) Helicases: amino acid sequence comparisons and structure-function relationships. Curr Opin Struct Biol 3, 419-429.
21. Cordin O, Banroques J, Tanner NK & Linder P (2006) The DEAD-box protein family of RNA helicases. Gene 367, 17-37.
22. Rocak S & Linder P (2004) DEAD-box proteins: the driving forces behind RNA metabolism. Nat Rev Mol Cell Biol 5, 232-241.
23. Silverman E, Edwalds-Gilbert G & Lin RJ (2003) DExD/H-box proteins and their partners: helping RNA helicases unwind. Gene 312, 1-16.
24. Tanner NK & Linder P (2001) DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell 8, 251-262.
25. de la Cruz J, Kressler D & Linder P (1999) Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. Trends Biochem Sci 24, 192-198.
26. Fuller-Pace FV (1994) RNA helicases: modulators of RNA structure. Trends Cell Biol 4, 271-274.
27. Schmid SR & Linder P (1992) D-E-A-D protein family of putative RNA helicases. Mol Microbiol 6, 283-291.
28. Iost I, Dreyfus M & Linder P (1999) Ded1p, a DEAD-box protein required for translation initiation in Saccharomyces cerevisiae, is an RNA helicase. J Biol Chem 274, 17677-17683.
29. Okanami M, Meshi T & Iwabuchi M (1998) Characterization of a DEAD box ATPase/RNA helicase protein of Arabidopsis thaliana. Nucleic Acids Res 26, 2638-2643.
30. Rogers GW Jr, Richter NJ & Merrick WC (1999) Biochemical and kinetic characterization of the RNA helicase activity of eukaryotic initiation factor 4A. J Biol Chem 274, 12236-12244.
31. Wagner JD, Jankowsky E, Company M, Pyle AM & Abelson JN (1998) The DEAH-box protein PRP22 is an ATPase that mediates ATP-dependent mRNA release from the spliceosome and unwinds RNA duplexes. EMBO J 17, 2926-29237.
32. Benz J, Trachsel H & Baumann U (1999) Crystal structure of the ATPase domain of translation initiation factor 4A from Saccharomyces cerevisiae - the prototype of the DEAD box protein family. Structure Fold Des 7, 671-679.
33. Caruthers JM, Johnson ER & McKay DB (2000) Crystal structure of yeast initiation factor 4A, a DEAD-box RNA helicase. Proc Natl Acad Sci USA 97, 13080-13085.
34. Caruthers JM & McKay DB (2002) Helicase structure and mechanism. Curr Opin Struct Biol 12, 123-133.
35. Gingras AC, Raught B & Sonenberg N (1999) eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem 68, 913-963.
36. Pain VM (1996) Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 236, 747-771.
37. Hershey JWB & MW (2000) Pathway and mechanism of initiation of protein synthesis. In Translational Control of Gene Expression (Sonenberg N, Hershey JWB & Mathews M, eds), pp. 33-88 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
38. Rhoads RE (1999) Signal transduction pathways that regulate eukaryotic protein synthesis. J Biol Chem 274, 30337-30340.
39. Bates EJ, Knuepfer E & Smith DF (2000) Poly(A)-binding protein I of Leishmania: functional analysis and localisation in trypanosomatid parasites. Nucleic Acids Res 28, 1211-1220.
40. Batista JA, Teixeira SM, Donelson JE, de Kirchhoff LV & CM (1994) Characterization of a Trypanosoma cruzi poly(A)-binding protein and its genes. Mol Biochem Parasitol 67, 301-312.
41. Hotchkiss TL, Nerantzakis GE, Dills SC, Shang L & Read LK (1999) Trypanosoma brucei poly(A) binding protein I cDNA cloning, expression, and binding to 5 untranslated region sequence elements. Mol Biochem Parasitol 98, 117-129.
42. Yoffe Y, Zuberek J, Lewdorowicz M, Zeira Z, Keasar C, Orr-Dahan I, Jankowska-Anyszka M, Stepinski J, Darzynkiewicz E & Shapira M (2004) Cap-binding activity of an eIF4E homolog from Leishmania. RNA 10, 1764-1775.
43. Chan CC, Dostie J, Diem MD, Feng W, Mann M, Rappsilber J & Dreyfuss G (2004) eIF4A3 is a novel component of the exon junction complex. RNA 10, 200-209.
44. Ferraiuolo MA, Lee CS, Ler LW, Hsu JL, Costa-Mattioli M, Luo MJ, Reed R & Sonenberg N (2004) A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay. Proc Natl Acad Sci USA 101, 4118-4123.
45. Palacios IM, Gatfield D, St Johnston D & Izaurralde E (2004) An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature 427, 753-757.
46. Shibuya T, Tange TO, Sonenberg N & Moore MJ (2004) eIF4AIII binds spliced mRNA in the exon junction complex and is essential for nonsense-mediated decay. Nat Struct Mol Biol 11, 346-351.
47. Li Q, Imataka H, Morino S, Rogers GW Jr, Richter-Cook NJ, Merrick WC & Sonenberg N (1999) Eukaryotic translation initiation factor 4AIII (eIF4AIII) is functionally distinct from eIF4AI and eIF4AII. Mol Cell Biol 19, 7336-7346.
48. Kressler D, de la Cruz J, Rojo M & Linder P (1997) Fal1p is an essential DEAD-box protein involved in 40S-ribosomal-subunit biogenesis in Saccharomyces cerevisiae. Mol Cell Biol 17, 7283-7294.
49. Tanner NK, Cordin O, Banroques J, Doere M & Linder P (2003) The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Mol Cell 11, 127-138.
50. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC & Sonenberg N (1990) Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10, 1134-1144.
51. Cordin O, Tanner NK, Doere M, Linder P & Banroques J (2004) The newly discovered Q motif of DEAD-box RNA helicases regulates RNA-binding and helicase activity. EMBO J 23, 2478-2487.
52. Oberer M, Marintchev A & Wagner G (2005) Structural basis for the enhancement of eIF4A helicase activity by eIF4G. Genes Dev 19, 2212-2223.
53. Rogers GW Jr, Richter NJ, Lima WF & Merrick WC (2001) Modulation of the helicase activity of eIF4A by eIF4B, eIF4H, and eIF4F. J Biol Chem 276, 30914-30922.
54. Schmid SR, Buser P, Coppolecchia R, Fischli A & Linder P (1993) Analysis of the genes encoding eIF-4A from yeast. In Protein Synthesis and Targeting in Yeast (Brown AJP, Tuite MF & McCarthy JEG, eds), pp. 131-142. Springer-Verlag, Berlin.
55. Dominguez D, Altmann M, Benz J, Baumann U & Trachsel H (1999) Interaction of translation initiation factor eIF4G with eIF4A in the yeast Saccharomyces cerevisiae. J Biol Chem 274, 26720-26726.
56. Korneeva NL, First EA, Benoit CA & Rhoads RE (2005) Interaction between the NH2-terminal domain of eIF4A and the central domain of eIF4G modulates RNA-stimulated ATPase activity. J Biol Chem 280, 1872-1881.
57. Rocak S, Emery B, Tanner NK & Linder P (2005) Characterization of the ATPase and unwinding activities of the yeast DEAD-box protein Has1p and the analysis of the roles of the conserved motifs. Nucleic Acids Res 33, 999-1009.
58. Yao N, Hesson T, Cable M, Hong Z, Kwong AD, Le HV & Weber PC (1997) Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol 4, 463-467.
59. Hirling H, Scheffner M, Restle T & Stahl H (1989) RNA helicase activity associated with the human p68 protein. Nature 339, 562-564.
60. Tsu CA & Uhlenbeck OC (1998) Kinetic analysis of the RNA-dependent adenosinetriphosphatase activity of DbpA, an Escherichia coli DEAD protein specific for 23S ribosomal RNA. Biochemistry 37, 16989-16996.
61. Lorsch JR & Herschlag D (1998) The DEAD box protein eIF4A. 1. A minimal kinetic and thermodynamic framework reveals coupled binding of RNA and nucleotide. Biochemistry 37, 2180-2193.
62. Nishi K, Morel-Deville F, Hershey JW, Leighton T & Schnier J (1988) An eIF-4A-like protein is a suppressor of an Escherichia coli mutant defective in 50S ribosomal subunit assembly. Nature 336, 496-498.
63. Flores-Rozas H & Hurwitz J (1993) Characterization of a new RNA helicase from nuclear extracts of HeLa cells which translocates in the 5′-to 3′ direction. J Biol Chem 268, 21372-21383.
64. Fuller-Pace FV, Nicol SM, Reid AD & Lane DP (1993) DbpA: a DEAD box protein specifically activated by 23s rRNA. EMBO J 12, 3619-3626.
65. Duncan R, Milburn SC & Hershey JW (1987) Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF-4F suggest a role in translational control. Heat shock effects on eIF-4F. J Biol Chem 262, 380-388.
66. von der Haar T & McCarthy JE (2002) Intracellular translation initiation factor levels in Saccharomyces cerevisiae and their role in cap-complex function. Mol Microbiol 46, 531-544.
67. Prat A, Schmid SR, Buser P, Blum S, Trachsel H, Nielsen PJ & Linder P (1990) Expression of translation initiation factor 4A from yeast and mouse in Saccharomyces cerevisiae. Biochim Biophys Acta 1050, 140-145.
68. Hentze MW (1997) eIF4G: a multipurpose ribosome adapter? Science 275, 500-501.
69. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, Sisk E, Rajandream MA, Adlem E, Aert R et al. (2005) The genome of the kinetoplastid parasite, Leishmania major. Science 309, 436-442.
70. Mayer MG & Floeter-Winter LM (2005) Pre-mRNA trans-splicing: from kinetoplastids to mammals, an easy language for life diversity. Mem Inst Oswaldo Cruz 100, 501-513.
71. Conti E & Izaurralde E (2005) Nonsense-mediated mRNA decay: molecular insights and mechanistic variations across species. Curr Opin Cell Biol 17, 316-325.
72. Dhalia R, Marinsek N, Reis CR, Katz R, Muniz JR, Standart N, Carrington M & de Melo Neto OP (2006) The two eIF4A helicases in Trypanosoma brucei are functionally distinct. Nucleic Acids Res 34, 2495-2507.
73. Kamoun-Essghaier S, Guizani I, Strub JM, Van Dorsselaer A, Mabrouk K, Ouelhazi L & Dellagi K (2005) Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients. Clin Diagn Lab Immunol 12, 310-320.
74. Nandan D & Reiner NE (2005) Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. Clin Immunol 114, 266-277.
75. Chang KP & McGwire BS (2002) Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol Dis 1, 1-7.
76. Xia Q, Kong XT, Zhang GA, Hou XJ, Qiang H & Zhong RQ (2005) Proteomics-based identification of DEAD-box protein 48 as a novel autoantigen, a prospective serum marker for pancreatic cancer. Biochem Biophys Res Commun 330, 526-532.
77. Karreman C (1998) Fusion PCR, a one-step variant of the 'megaprimer' method of mutagenesis. Biotechniques 24, 736,740,742.
78. Guthrie C & Fink GR (1991) Guide to Yeast Genetics and Molecular Biology. In Methods in Enzymology (Abelson JN & Simon MI, series eds) 194, Academic Press, San Diego.